Suranganie Dharmawardhane
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| rac GTP-Binding Proteins | 10 | 2024 | 26 | 3.670 |
Why?
|
| cdc42 GTP-Binding Protein | 7 | 2021 | 25 | 2.690 |
Why?
|
| Breast Neoplasms | 17 | 2021 | 1723 | 2.330 |
Why?
|
| rac1 GTP-Binding Protein | 7 | 2025 | 50 | 2.110 |
Why?
|
| Stilbenes | 8 | 2016 | 44 | 1.810 |
Why?
|
| Carbazoles | 7 | 2021 | 49 | 1.720 |
Why?
|
| Antineoplastic Agents | 9 | 2019 | 1019 | 1.600 |
Why?
|
| Pyrimidines | 7 | 2021 | 139 | 1.560 |
Why?
|
| Cell Line, Tumor | 22 | 2025 | 2676 | 1.130 |
Why?
|
| Vitis | 4 | 2016 | 37 | 1.130 |
Why?
|
| Isoflavones | 5 | 2021 | 132 | 0.980 |
Why?
|
| GTP-Binding Proteins | 4 | 2022 | 59 | 0.950 |
Why?
|
| Neoplasm Metastasis | 7 | 2017 | 237 | 0.920 |
Why?
|
| Eukaryotic Initiation Factor-4G | 3 | 2015 | 14 | 0.910 |
Why?
|
| Catechin | 3 | 2016 | 39 | 0.860 |
Why?
|
| Quercetin | 3 | 2016 | 46 | 0.850 |
Why?
|
| Paclitaxel | 1 | 2024 | 64 | 0.850 |
Why?
|
| Genistein | 3 | 2016 | 45 | 0.800 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 968 | 0.790 |
Why?
|
| Cell Proliferation | 14 | 2025 | 1455 | 0.790 |
Why?
|
| Mice | 18 | 2024 | 6644 | 0.730 |
Why?
|
| Enzyme Inhibitors | 3 | 2013 | 458 | 0.690 |
Why?
|
| Cell Movement | 9 | 2025 | 655 | 0.670 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 159 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2015 | 63 | 0.610 |
Why?
|
| Actins | 4 | 2007 | 164 | 0.610 |
Why?
|
| Cytoskeleton | 5 | 2007 | 114 | 0.610 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 220 | 0.590 |
Why?
|
| Cell Polarity | 2 | 2018 | 57 | 0.590 |
Why?
|
| Saccharomycetales | 1 | 2018 | 8 | 0.570 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 307 | 0.560 |
Why?
|
| Animals | 24 | 2024 | 16992 | 0.550 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2016 | 299 | 0.530 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2009 | 69 | 0.530 |
Why?
|
| Female | 25 | 2024 | 24698 | 0.530 |
Why?
|
| Mice, Nude | 7 | 2016 | 408 | 0.530 |
Why?
|
| Cell Survival | 8 | 2017 | 945 | 0.490 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 139 | 0.480 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2016 | 134 | 0.480 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 465 | 0.470 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 241 | 0.470 |
Why?
|
| Protein Biosynthesis | 2 | 2015 | 132 | 0.470 |
Why?
|
| Receptors, Estrogen | 3 | 2015 | 183 | 0.470 |
Why?
|
| Signal Transduction | 5 | 2018 | 2157 | 0.460 |
Why?
|
| Breast | 1 | 2016 | 139 | 0.450 |
Why?
|
| Mice, SCID | 4 | 2021 | 158 | 0.440 |
Why?
|
| Drug Design | 2 | 2013 | 186 | 0.440 |
Why?
|
| Humans | 34 | 2025 | 43102 | 0.440 |
Why?
|
| Estradiol | 3 | 2007 | 268 | 0.430 |
Why?
|
| p21-Activated Kinases | 6 | 2013 | 21 | 0.420 |
Why?
|
| Phytoestrogens | 2 | 2012 | 39 | 0.390 |
Why?
|
| Apoptosis | 5 | 2024 | 1568 | 0.370 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2013 | 65 | 0.370 |
Why?
|
| Quinazolines | 1 | 2012 | 38 | 0.360 |
Why?
|
| Reishi | 1 | 2011 | 10 | 0.350 |
Why?
|
| Up-Regulation | 3 | 2021 | 536 | 0.340 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2024 | 347 | 0.320 |
Why?
|
| Pseudopodia | 4 | 2007 | 17 | 0.310 |
Why?
|
| MicroRNAs | 1 | 2016 | 518 | 0.310 |
Why?
|
| Plant Extracts | 1 | 2013 | 302 | 0.310 |
Why?
|
| Pinocytosis | 2 | 2000 | 10 | 0.300 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2009 | 22 | 0.300 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 49 | 0.290 |
Why?
|
| Neoplasms | 2 | 2018 | 1377 | 0.290 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 182 | 0.280 |
Why?
|
| Aminoquinolines | 3 | 2013 | 17 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2025 | 8 | 0.260 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2007 | 19 | 0.260 |
Why?
|
| Luminescent Agents | 1 | 2006 | 4 | 0.260 |
Why?
|
| Luminescent Proteins | 1 | 2006 | 68 | 0.250 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 184 | 0.240 |
Why?
|
| Estrogens | 1 | 2007 | 203 | 0.230 |
Why?
|
| Cell Division | 2 | 2022 | 311 | 0.230 |
Why?
|
| Focal Adhesions | 1 | 2005 | 16 | 0.220 |
Why?
|
| Adenocarcinoma | 1 | 2007 | 291 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 2 | 2024 | 694 | 0.200 |
Why?
|
| Carbon | 1 | 2024 | 128 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2016 | 456 | 0.200 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2019 | 1124 | 0.190 |
Why?
|
| Molecular Structure | 4 | 2019 | 570 | 0.190 |
Why?
|
| Neoplasm Invasiveness | 3 | 2011 | 290 | 0.190 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 34 | 0.190 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 157 | 0.190 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 129 | 0.180 |
Why?
|
| Cell Cycle | 2 | 2016 | 346 | 0.170 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 37 | 0.170 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 40 | 0.170 |
Why?
|
| Point Mutation | 1 | 2021 | 98 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2014 | 883 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 1596 | 0.170 |
Why?
|
| Estrogen Receptor beta | 3 | 2013 | 39 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 5 | 2014 | 508 | 0.160 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2019 | 14 | 0.160 |
Why?
|
| Estrogen Receptor alpha | 3 | 2013 | 121 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1999 | 25 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 196 | 0.150 |
Why?
|
| Disease Progression | 3 | 2019 | 667 | 0.150 |
Why?
|
| Adipocytes | 1 | 2019 | 60 | 0.150 |
Why?
|
| Phagocytosis | 1 | 1999 | 86 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 296 | 0.140 |
Why?
|
| Cell Communication | 1 | 2019 | 114 | 0.140 |
Why?
|
| Neutrophils | 1 | 1999 | 145 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 196 | 0.140 |
Why?
|
| Cytoplasmic Granules | 1 | 1997 | 9 | 0.140 |
Why?
|
| Indoles | 1 | 2019 | 187 | 0.130 |
Why?
|
| GTP Phosphohydrolases | 1 | 1997 | 34 | 0.130 |
Why?
|
| Leukocytes | 1 | 1997 | 80 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 611 | 0.120 |
Why?
|
| Dietary Supplements | 2 | 2021 | 213 | 0.120 |
Why?
|
| Epidermal Growth Factor | 2 | 2007 | 70 | 0.120 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 68 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1092 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 59 | 0.120 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 7 | 0.110 |
Why?
|
| Protein Binding | 1 | 2018 | 1082 | 0.110 |
Why?
|
| Pregnenolone | 1 | 2014 | 17 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 14 | 0.100 |
Why?
|
| Linear Models | 1 | 2015 | 317 | 0.100 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 71 | 0.100 |
Why?
|
| Hela Cells | 1 | 2015 | 376 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2013 | 38 | 0.100 |
Why?
|
| Mice, Hairless | 1 | 2013 | 7 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 1997 | 561 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 652 | 0.100 |
Why?
|
| Transfection | 2 | 2007 | 532 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 25 | 0.100 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 18 | 0.100 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 98 | 0.100 |
Why?
|
| Microscopy, Confocal | 3 | 2004 | 224 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2012 | 28 | 0.090 |
Why?
|
| Adenylate Kinase | 1 | 2012 | 14 | 0.090 |
Why?
|
| Catenins | 1 | 2011 | 5 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 27 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 51 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2013 | 462 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1271 | 0.090 |
Why?
|
| Sirolimus | 1 | 2012 | 70 | 0.090 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 76 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1081 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2012 | 227 | 0.090 |
Why?
|
| Cadherins | 1 | 2011 | 102 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 671 | 0.080 |
Why?
|
| Postmenopause | 2 | 2021 | 141 | 0.080 |
Why?
|
| 3T3 Cells | 2 | 2000 | 64 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2005 | 403 | 0.080 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2000 | 28 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1151 | 0.070 |
Why?
|
| Saponins | 1 | 2007 | 7 | 0.070 |
Why?
|
| Asteraceae | 1 | 2007 | 4 | 0.070 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 2005 | 22 | 0.070 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2005 | 21 | 0.070 |
Why?
|
| Triterpenes | 1 | 2007 | 18 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 2007 | 20 | 0.070 |
Why?
|
| Optical Fibers | 1 | 2006 | 8 | 0.060 |
Why?
|
| Fiber Optic Technology | 1 | 2006 | 11 | 0.060 |
Why?
|
| Optics and Photonics | 1 | 2007 | 34 | 0.060 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 27 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 139 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1070 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 53 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2009 | 358 | 0.060 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 62 | 0.050 |
Why?
|
| Inflammation | 2 | 2019 | 758 | 0.050 |
Why?
|
| Phenotype | 1 | 2005 | 780 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2002 | 29 | 0.040 |
Why?
|
| Flavonoids | 1 | 2002 | 100 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 704 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2002 | 94 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2000 | 9 | 0.040 |
Why?
|
| Dextrans | 1 | 2000 | 29 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 135 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2000 | 165 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 186 | 0.040 |
Why?
|
| Biological Transport | 1 | 2000 | 204 | 0.040 |
Why?
|
| Zymosan | 1 | 1999 | 2 | 0.040 |
Why?
|
| Opsonin Proteins | 1 | 1999 | 2 | 0.040 |
Why?
|
| Cytochalasin D | 1 | 1999 | 4 | 0.040 |
Why?
|
| Complement C3b | 1 | 1999 | 4 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2019 | 49 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1999 | 6 | 0.040 |
Why?
|
| 3T3-L1 Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Androstadienes | 1 | 1999 | 19 | 0.040 |
Why?
|
| Culture Media | 1 | 2019 | 96 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2000 | 192 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2014 | 411 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 518 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 1999 | 256 | 0.040 |
Why?
|
| Genes, src | 1 | 1997 | 3 | 0.030 |
Why?
|
| Cell Transformation, Viral | 1 | 1997 | 24 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 506 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 241 | 0.030 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 1997 | 1 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2014 | 986 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1997 | 68 | 0.030 |
Why?
|
| Dictyostelium | 1 | 1997 | 45 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1997 | 142 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 1997 | 191 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2014 | 13 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 55 | 0.030 |
Why?
|
| Calibration | 1 | 2014 | 63 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 114 | 0.030 |
Why?
|
| beta Catenin | 1 | 2014 | 78 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 84 | 0.030 |
Why?
|
| Mastocytosis | 1 | 2013 | 3 | 0.030 |
Why?
|
| Adult | 2 | 2021 | 13872 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 80 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 195 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 458 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 91 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3156 | 0.020 |
Why?
|
| Mutation | 1 | 1997 | 1177 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 372 | 0.020 |
Why?
|
| Liver | 1 | 2014 | 511 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 140 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 301 | 0.020 |
Why?
|
| Contrast Media | 1 | 2007 | 103 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 12222 | 0.010 |
Why?
|
| Male | 1 | 2025 | 23409 | 0.010 |
Why?
|
| Streptavidin | 1 | 2004 | 6 | 0.010 |
Why?
|
| Fluorometry | 1 | 2004 | 17 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2004 | 30 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2004 | 107 | 0.010 |
Why?
|
| Mouth Neoplasms | 1 | 2004 | 60 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 177 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2004 | 83 | 0.010 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2002 | 20 | 0.010 |
Why?
|
| Plant Preparations | 1 | 2002 | 24 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 257 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 18 | 0.010 |
Why?
|
| Morphogenesis | 1 | 1997 | 48 | 0.010 |
Why?
|